H.A.C. PHARMA   Report issue

For profit Phase 4
Founded: Caen France (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2019
NCT04128137
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

H.A.C. PHARMA

Active Ingredients

Drugs in Phase 4 Trials (1)

fludrocortisone (florinef) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypotension (Phase 4)

Hypotension, Orthostatic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1